GlaxoSmithKline

The House Oversight Committee has launched an investigation into 23andMe over the risk of the company selling customers' genetic material and information amid the biotech firm's bankruptcy.

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder

More than half of patients tested positive for CSF-ctDNA, high concordance with tumor mutations

The World Health Organization (WHO) is sponsoring a malaria vaccine study in African children without obtaining informed consent from parents.

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly becoming treatment-resistant.

Two phase III trials suggest there is a safe option for daily ART without an integrase inhibitor

Yes, study suggests, but results may not represent a meaningful impact, expert says

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ulcerative colitis as well as in those with Crohn's disease.

Biologic went head to head against ustekinumab in SEQUENCE trial

Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Fewer complications and flares occur for those who achieve the target, even intermittently

23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low dose, though these flares were minor.

Long-lived plasma cell compartment in the bone marrow may hold the answer, says researcher

Choice of vaccine critic knocks some of world's biggest drugmakers including Moderna, AstraZeneca and GSK

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Human papilloma virus vaccine has cut rates of cervical cancer, oropharyngeal cancers, as well as anogenital malignancies and infections linked to genital warts.

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in the country